Jefferson University Hospitals

Physician Profile

Carl Regillo, MD

Academic Title: Professor

Specialties
Ophthalmology - Retina

Make An Appointment

Click to call 1-800-JEFF-NOW (800-533-3669) or

Office Locations

Philadelphia
840 Walnut Street
Suite 1020
Philadelphia PA 19107
Phone: (800) 331-6634

Medical Services

Years in Practice

25

Board Certifications

  • Ophthalmology

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital

Awards and Honors

Philadelphia Magazine's Top Docs 2016,2015,2014,2012,2011,2010

Education

  • Harvard Medical School, Medical School

Internship

  • Brigham & Women's Hospital

Residency

  • Wills Eye Hospital

Fellowship

  • Wills Eye Hospital

Recent Publications

RHEGMATOGENOUS RETINAL DETACHMENT after INTRAARTERIAL CHEMOTHERAPY for RETINOBLASTOMA: The 2016 Founders Award Lecture

Treat-and-Extend Therapy Using Aflibercept for Neovascular Age-related Macular Degeneration: A Prospective Clinical Trial

Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration

Economic Evaluation of a Home-Based Age-Related Macular Degeneration Monitoring System

Reply

Use of corticosteroids in the treatment of patients with diabetic macular edema who have a suboptimal response to anti-VEGF: Recommendations of an expert panel

27-GAUGE VITRECTOMY WOUND INTEGRITY: A Randomized Pilot Study Comparing Angled Versus Straight Entry in Fluid-Filled Vitrectomized Eyes

The potential importance of detection of neovascular age-related macular degeneration when visual acuity is relatively good

Re: Effect of Aflibercept on Refractory Macular Edema Associated with Central Retinal Vein Occlusion

MINIMAL ENDOILLUMINATION LEVELS AND DISPLAY LUMINOUS EMITTANCE DURING THREE-DIMENSIONAL HEADS-UP VITREORETINAL SURGERY

Baseline Choroidal Thickness as a Predictor for Treatment Outcomes in Central Retinal Vein Occlusion

Effect of aflibercept on refractory macular edema associated with central retinal vein occlusion

Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial

A team-based approach to treating advanced macular degeneration: The combination of candidate selection, occupational therapy, and implantable miniature telescope surgery is not a one-person job

Vitrectomy after ocriplasmin for VitreOmacular adhesion or Macular hole (VAVOOM) study

Baseline predictors of vitreomacular adhesion/traction resolution following an intravitreal injection of ocriplasmin

Predictors of Diabetic Macular Edema Treatment Frequency with Ranibizumab During the Open-Label Extension of the RIDE and RISE Trials

Reply

Ophthalmic Complications Associated with Direct Oral Anticoagulant Medications

Treatment outcomes for neovascular age-related macular degeneration patients with initial vision better than 20/40 using a treat-and-extend regimen